Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Boston Scientific Corp has a consensus price target of $105.52 based on the ratings of 24 analysts. The high is $130 issued by UBS on February 7, 2025. The low is $68 issued by Oppenheimer on February 1, 2024. The 3 most-recent analyst ratings were released by Stifel, Barclays, and UBS on February 10, 2025, February 10, 2025, and February 7, 2025, respectively. With an average price target of $122.67 between Stifel, Barclays, and UBS, there's an implied 19.41% upside for Boston Scientific Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/03/2025 | Buy Now | — | Needham | Mike Matson57% | — | Reiterates | Hold → Hold | Get Alert |
02/10/2025 | Buy Now | 16.82% | Stifel | Rick Wise74% | $115 → $120 | Maintains | Buy | Get Alert |
02/10/2025 | Buy Now | 14.87% | Barclays | Matt Miksic67% | $111 → $118 | Maintains | Overweight | Get Alert |
02/07/2025 | Buy Now | 26.55% | UBS | Danielle Antalffy58% | $105 → $130 | Maintains | Buy | Get Alert |
02/06/2025 | Buy Now | 18.76% | Raymond James | Jayson Bedford69% | $119 → $122 | Maintains | Strong Buy | Get Alert |
02/06/2025 | Buy Now | 12.92% | RBC Capital | Shagun Singh58% | $105 → $116 | Maintains | Outperform | Get Alert |
02/06/2025 | Buy Now | 11.95% | Stifel | Rick Wise74% | $100 → $115 | Maintains | Buy | Get Alert |
02/06/2025 | Buy Now | 14.87% | Wells Fargo | Larry Biegelsen69% | $100 → $118 | Maintains | Overweight | Get Alert |
02/06/2025 | Buy Now | 18.76% | Citigroup | Joanne Wuensch75% | $107 → $122 | Maintains | Buy | Get Alert |
02/06/2025 | Buy Now | 16.82% | Morgan Stanley | Patrick Wood52% | $100 → $120 | Maintains | Overweight | Get Alert |
02/06/2025 | Buy Now | — | Needham | Mike Matson57% | — | Reiterates | Hold → Hold | Get Alert |
02/03/2025 | Buy Now | 11.95% | Piper Sandler | Matt O'Brien51% | $95 → $115 | Maintains | Overweight | Get Alert |
01/31/2025 | Buy Now | 15.84% | Raymond James | Jayson Bedford69% | $101 → $119 | Maintains | Strong Buy | Get Alert |
12/18/2024 | Buy Now | 7.08% | Truist Securities | Richard Newitter73% | $100 → $110 | Maintains | Buy | Get Alert |
12/16/2024 | Buy Now | 7.08% | JP Morgan | Robbie Marcus67% | $100 → $110 | Maintains | Overweight | Get Alert |
12/12/2024 | Buy Now | 7.08% | TD Cowen | Joshua Jennings55% | $100 → $110 | Maintains | Buy | Get Alert |
12/11/2024 | Buy Now | 4.16% | Citigroup | Joanne Wuensch75% | $98 → $107 | Maintains | Buy | Get Alert |
12/11/2024 | Buy Now | -2.65% | Wells Fargo | Larry Biegelsen69% | $98 → $100 | Maintains | Overweight | Get Alert |
12/09/2024 | Buy Now | -1.68% | Canaccord Genuity | William Plovanic58% | $98 → $101 | Maintains | Buy | Get Alert |
11/27/2024 | Buy Now | — | Needham | Mike Matson57% | — | Reiterates | → Hold | Get Alert |
11/18/2024 | Buy Now | — | Needham | Mike Matson57% | — | Reiterates | → Hold | Get Alert |
10/31/2024 | Buy Now | — | Needham | Mike Matson57% | — | Reiterates | → Hold | Get Alert |
10/24/2024 | Buy Now | -2.65% | Bernstein | Lee Hambright68% | $92 → $100 | Maintains | Outperform | Get Alert |
10/24/2024 | Buy Now | -2.65% | Morgan Stanley | Patrick Wood52% | $92 → $100 | Maintains | Overweight | Get Alert |
10/24/2024 | Buy Now | -4.6% | RBC Capital | Shagun Singh58% | $95 → $98 | Maintains | Outperform | Get Alert |
10/24/2024 | Buy Now | -4.6% | Wells Fargo | Larry Biegelsen69% | $87 → $98 | Maintains | Overweight | Get Alert |
10/24/2024 | Buy Now | -4.6% | Citigroup | Joanne Wuensch75% | $92 → $98 | Maintains | Buy | Get Alert |
10/24/2024 | Buy Now | -4.6% | Canaccord Genuity | William Plovanic58% | $98 → $98 | Maintains | Buy | Get Alert |
10/24/2024 | Buy Now | 7.08% | Mizuho | Anthony Petrone65% | $100 → $110 | Maintains | Outperform | Get Alert |
10/24/2024 | Buy Now | — | Needham | Mike Matson57% | — | Reiterates | → Hold | Get Alert |
10/22/2024 | Buy Now | -2.65% | B of A Securities | Bob Hopkins48% | $90 → $100 | Maintains | Buy | Get Alert |
10/21/2024 | Buy Now | -2.65% | TD Cowen | Joshua Jennings55% | $86 → $100 | Maintains | Buy | Get Alert |
10/21/2024 | Buy Now | -4.6% | Canaccord Genuity | William Plovanic58% | $88 → $98 | Maintains | Buy | Get Alert |
10/18/2024 | Buy Now | -2.65% | Stifel | Rick Wise74% | $85 → $100 | Maintains | Buy | Get Alert |
10/18/2024 | Buy Now | -16.28% | Needham | Mike Matson57% | $86 → $86 | Downgrade | Buy → Hold | Get Alert |
10/14/2024 | Buy Now | -9.47% | BTIG | Marie Thibault64% | $84 → $93 | Maintains | Buy | Get Alert |
10/14/2024 | Buy Now | -2.65% | Truist Securities | Richard Newitter73% | $90 → $100 | Maintains | Buy | Get Alert |
10/08/2024 | Buy Now | -7.52% | RBC Capital | Shagun Singh58% | $85 → $95 | Maintains | Outperform | Get Alert |
10/01/2024 | Buy Now | -12.39% | Evercore ISI Group | Vijay Kumar53% | $82 → $90 | Maintains | Outperform | Get Alert |
09/04/2024 | Buy Now | -8.49% | Raymond James | Jayson Bedford69% | $91 → $94 | Maintains | Strong Buy | Get Alert |
08/22/2024 | Buy Now | -10.44% | Citigroup | Joanne Wuensch75% | $90 → $92 | Maintains | Buy | Get Alert |
08/22/2024 | Buy Now | -16.28% | Barclays | Matt Miksic67% | $78 → $86 | Maintains | Overweight | Get Alert |
07/25/2024 | Buy Now | -11.41% | Raymond James | Jayson Bedford69% | $85 → $91 | Maintains | Strong Buy | Get Alert |
07/25/2024 | Buy Now | -24.07% | Deutsche Bank | Pito Chickering66% | $73 → $78 | Maintains | Hold | Get Alert |
07/25/2024 | Buy Now | -17.25% | RBC Capital | Shagun Singh58% | $82 → $82 | Reiterates | Outperform → Outperform | Get Alert |
07/25/2024 | Buy Now | -17.25% | JP Morgan | Robbie Marcus67% | $82 → $85 | Maintains | Overweight | Get Alert |
07/25/2024 | Buy Now | -14.33% | Canaccord Genuity | William Plovanic58% | $83 → $88 | Maintains | Buy | Get Alert |
07/25/2024 | Buy Now | -11.41% | Baird | David Rescott61% | $90 → $91 | Maintains | Outperform | Get Alert |
07/25/2024 | Buy Now | -16.28% | Needham | Mike Matson57% | $82 → $86 | Maintains | Buy | Get Alert |
07/16/2024 | Buy Now | -16.28% | TD Cowen | Joshua Jennings55% | $77 → $86 | Maintains | Buy | Get Alert |
07/16/2024 | Buy Now | -12.39% | Truist Securities | Richard Newitter73% | $86 → $90 | Maintains | Buy | Get Alert |
07/15/2024 | Buy Now | -18.23% | BTIG | Marie Thibault64% | $80 → $84 | Maintains | Buy | Get Alert |
07/15/2024 | Buy Now | -10.44% | Morgan Stanley | Patrick Wood52% | $79 → $92 | Maintains | Overweight | Get Alert |
07/10/2024 | Buy Now | -12.39% | Citigroup | Joanne Wuensch75% | $87 → $90 | Maintains | Buy | Get Alert |
07/02/2024 | Buy Now | -21.15% | Evercore ISI Group | Vijay Kumar53% | $78 → $81 | Maintains | Outperform | Get Alert |
06/18/2024 | Buy Now | -20.18% | Needham | Mike Matson57% | $82 → $82 | Reiterates | Buy → Buy | Get Alert |
05/30/2024 | Buy Now | -12.39% | Goldman Sachs | David Roman37% | → $90 | Initiates | → Buy | Get Alert |
05/28/2024 | Buy Now | -7.52% | Argus Research | John Eade74% | $80 → $95 | Maintains | Buy | Get Alert |
05/22/2024 | Buy Now | -15.31% | Citigroup | Joanne Wuensch75% | $85 → $87 | Maintains | Buy | Get Alert |
05/15/2024 | Buy Now | -12.39% | Mizuho | Anthony Petrone65% | $85 → $90 | Maintains | Buy | Get Alert |
04/26/2024 | Buy Now | -24.07% | Barclays | Matt Miksic67% | $70 → $78 | Maintains | Overweight | Get Alert |
04/25/2024 | Buy Now | -17.25% | Citigroup | Joanne Wuensch75% | $79 → $85 | Maintains | Buy | Get Alert |
04/25/2024 | Buy Now | -28.94% | Deutsche Bank | Pito Chickering66% | $63 → $73 | Maintains | Hold | Get Alert |
04/25/2024 | Buy Now | -20.18% | JP Morgan | Robbie Marcus67% | $72 → $82 | Maintains | Overweight | Get Alert |
04/25/2024 | Buy Now | -17.25% | Raymond James | Jayson Bedford69% | $73 → $85 | Maintains | Strong Buy | Get Alert |
04/25/2024 | Buy Now | -20.18% | RBC Capital | Shagun Singh58% | $78 → $82 | Maintains | Outperform | Get Alert |
04/25/2024 | Buy Now | -17.25% | Mizuho | Anthony Petrone65% | $80 → $85 | Maintains | Buy | Get Alert |
04/25/2024 | Buy Now | -12.39% | UBS | Danielle Antalffy58% | $74 → $90 | Maintains | Buy | Get Alert |
04/25/2024 | Buy Now | -20.18% | Wells Fargo | Larry Biegelsen69% | $72 → $82 | Maintains | Overweight | Get Alert |
04/25/2024 | Buy Now | -24.07% | Evercore ISI Group | Vijay Kumar53% | $72 → $78 | Maintains | Outperform | Get Alert |
04/25/2024 | Buy Now | -18.23% | Baird | David Rescott61% | $79 → $84 | Maintains | Outperform | Get Alert |
04/24/2024 | Buy Now | -20.18% | Needham | Mike Matson57% | $71 → $82 | Maintains | Buy | Get Alert |
04/15/2024 | Buy Now | -24.07% | RBC Capital | Shagun Singh58% | $70 → $78 | Maintains | Outperform | Get Alert |
04/04/2024 | Buy Now | -29.91% | Evercore ISI Group | Vijay Kumar53% | $68 → $72 | Maintains | Outperform | Get Alert |
04/03/2024 | Buy Now | -22.12% | Argus Research | John Eade74% | $69 → $80 | Maintains | Buy | Get Alert |
04/03/2024 | Buy Now | -23.1% | Citigroup | Joanne Wuensch75% | $71 → $79 | Maintains | Buy | Get Alert |
03/07/2024 | Buy Now | -25.04% | TD Cowen | Joshua Jennings55% | $65 → $77 | Maintains | Outperform | Get Alert |
02/05/2024 | Buy Now | -31.86% | RBC Capital | Shagun Singh58% | $70 → $70 | Reiterates | Outperform → Outperform | Get Alert |
02/01/2024 | Buy Now | -30.88% | Citigroup | Joanne Wuensch75% | $65 → $71 | Maintains | Buy | Get Alert |
02/01/2024 | Buy Now | -30.88% | Needham | Mike Matson57% | $60 → $71 | Maintains | Buy | Get Alert |
02/01/2024 | Buy Now | -28.94% | Raymond James | Jayson Bedford69% | $67 → $73 | Maintains | Strong Buy | Get Alert |
02/01/2024 | Buy Now | -33.8% | Oppenheimer | Steven Lichtman66% | $58 → $68 | Maintains | Perform | Get Alert |
02/01/2024 | Buy Now | -22.12% | Mizuho | Anthony Petrone65% | → $80 | Upgrade | Neutral → Buy | Get Alert |
02/01/2024 | Buy Now | -31.86% | RBC Capital | Shagun Singh58% | $67 → $70 | Maintains | Outperform | Get Alert |
02/01/2024 | Buy Now | -29.91% | JP Morgan | Robbie Marcus67% | $60 → $72 | Maintains | Overweight | Get Alert |
02/01/2024 | Buy Now | -29.91% | Wells Fargo | Larry Biegelsen69% | $70 → $72 | Maintains | Overweight | Get Alert |
01/16/2024 | Buy Now | -34.78% | RBC Capital | Shagun Singh58% | $67 → $67 | Reiterates | Outperform → Outperform | Get Alert |
01/03/2024 | Buy Now | -34.78% | Raymond James | Jayson Bedford69% | $61 → $67 | Maintains | Strong Buy | Get Alert |
12/29/2023 | Buy Now | -37.7% | BTIG | Marie Thibault64% | $64 → $64 | Reiterates | Buy → Buy | Get Alert |
12/29/2023 | Buy Now | -39.64% | Wells Fargo | Larry Biegelsen69% | $62 → $62 | Reiterates | Overweight → Overweight | Get Alert |
12/22/2023 | Buy Now | -35.75% | Truist Securities | Richard Newitter73% | $59 → $66 | Maintains | Buy | Get Alert |
12/13/2023 | Buy Now | -39.64% | Wells Fargo | Larry Biegelsen69% | $59 → $62 | Maintains | Overweight | Get Alert |
12/12/2023 | Buy Now | -36.72% | TD Cowen | Joshua Jennings55% | $58 → $65 | Maintains | Outperform | Get Alert |
12/04/2023 | Buy Now | -40.62% | Morgan Stanley | Patrick Wood52% | $58 → $61 | Maintains | Overweight | Get Alert |
11/27/2023 | Buy Now | -37.7% | Canaccord Genuity | William Plovanic58% | $60 → $64 | Maintains | Buy | Get Alert |
10/27/2023 | Buy Now | -41.59% | Needham | Mike Matson57% | $65 → $60 | Maintains | Buy | Get Alert |
09/22/2023 | Buy Now | -41.59% | Barclays | Matt Miksic67% | $59 → $60 | Maintains | Overweight | Get Alert |
09/21/2023 | Buy Now | -40.62% | Truist Securities | Richard Newitter73% | → $61 | Reiterates | Buy → Buy | Get Alert |
09/21/2023 | Buy Now | -38.67% | Baird | David Rescott61% | $60 → $63 | Maintains | Outperform | Get Alert |
09/21/2023 | Buy Now | -41.59% | Mizuho | Anthony Petrone65% | $56 → $60 | Maintains | Neutral | Get Alert |
The latest price target for Boston Scientific (NYSE:BSX) was reported by Needham on March 3, 2025. The analyst firm set a price target for $0.00 expecting BSX to fall to within 12 months (a possible -100.00% downside). 76 analyst firms have reported ratings in the last year.
The latest analyst rating for Boston Scientific (NYSE:BSX) was provided by Needham, and Boston Scientific reiterated their hold rating.
The last upgrade for Boston Scientific Corp happened on February 1, 2024 when Mizuho raised their price target to $80. Mizuho previously had a neutral for Boston Scientific Corp.
The last downgrade for Boston Scientific Corp happened on October 18, 2024 when Needham changed their price target from $86 to $86 for Boston Scientific Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Boston Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Boston Scientific was filed on March 3, 2025 so you should expect the next rating to be made available sometime around March 3, 2026.
While ratings are subjective and will change, the latest Boston Scientific (BSX) rating was a reiterated with a price target of $0.00 to $0.00. The current price Boston Scientific (BSX) is trading at is $102.73, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.